Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Investigating the Effects of Receptor Clustering on Immune Cell Activation using Multivalent Synthetic Probes to Guide Cancer Immunotherapeutic Design
FY 2021-22
Summary
Cancer immunotherapy works by using the bodys own immune system to treat cancer. A type of immunotherapeutic known as ;molecular adapters work by binding immune cells and linking them to targeted tumour cells, allowing the immune cells to kill the tumour cells. One way that immune cells kill is through phagocytosis, which is activated by the clustering of Fc receptors on the cell surface. How molecular adapters interact with immune receptors to modulate receptor clustering is unknown. We hypothesize that the efficacy of Fc clustering and the resultant anti-tumour response of molecular adapters depend on the number, spatial array, and stability of interactions between the molecular adapters and the receptors. We will use a synthetic, multivalent DNA scaffold that can precisely tune these parameters to investigate their effects on immune cell activation. The DNA scaffold will have CP33, a peptide known to bind the humanFcγRI immune receptor, anchored to it at selected locations using click chemistry. We plan to synthesize several different scaffolds that will bind a different number ofFcγRI receptors and hold those receptors at different distances apart on the cell surface. We will then use immunobiological flow cytometry assays the asses the level of immune cell activation that results from treatment with the different scaffolds. These findings will not only further our understanding of how the anti-tumour response of molecular adapters is impacted by the interactions between the molecular adapters and immune cell receptors, but they can also be used to guide future immunotherapeutic design. The CP33 peptide can be easily replaced by novel peptides that bind other immune receptors, allowing this platform to be adapted to study different receptors in future research.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466842
Name
Yang Zi Ling
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Effects of Receptor Clustering on Immune Cell Activation using Multivalent Synthetic Probes to Guide Cancer Immunotherapeutic Design
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomolecular Interactions; Cancer Therapeutics Design; Immune Cell Activation; Immunology; Immunotherapy; Molecular Adapters; Multivalent Probes; Receptor Clustering
Abstract
Cancer immunotherapy works by using the bodys own immune system to treat cancer. A type of immunotherapeutic known as ;molecular adapters work by binding immune cells and linking them to targeted tumour cells, allowing the immune cells to kill the tumour cells. One way that immune cells kill is through phagocytosis, which is activated by the clustering of Fc receptors on the cell surface. How molecular adapters interact with immune receptors to modulate receptor clustering is unknown. We hypothesize that the efficacy of Fc clustering and the resultant anti-tumour response of molecular adapters depend on the number, spatial array, and stability of interactions between the molecular adapters and the receptors. We will use a synthetic, multivalent DNA scaffold that can precisely tune these parameters to investigate their effects on immune cell activation. The DNA scaffold will have CP33, a peptide known to bind the humanFcγRI immune receptor, anchored to it at selected locations using click chemistry. We plan to synthesize several different scaffolds that will bind a different number ofFcγRI receptors and hold those receptors at different distances apart on the cell surface. We will then use immunobiological flow cytometry assays the asses the level of immune cell activation that results from treatment with the different scaffolds. These findings will not only further our understanding of how the anti-tumour response of molecular adapters is impacted by the interactions between the molecular adapters and immune cell receptors, but they can also be used to guide future immunotherapeutic design. The CP33 peptide can be easily replaced by novel peptides that bind other immune receptors, allowing this platform to be adapted to study different receptors in future research.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yang, Zi Ling
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~